CTAB Enhances Chemo-Sensitivity Through Activation of AMPK Signaling Cascades in Breast Cancer

• Autores principales: Yue Pan (Autor), Yunqiu Zhang (Autor), Qing Chen (Autor), Xufeng Tao (Autor), Jianzhou Liu (Autor), Gary Guishan Xiao (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2019-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Metabolic reprogramming is thought to be one of the initiators in cancer drug resistance. It has been shown that CTAB is capable of interfering the efficiency of cancer therapy by regulation of cell metabolic reprogramming. In this study, we hypothesized that AMPK as a key metabolic regulator plays...